Abstract We previously reported that Trypanosoma cruzi, the agent of Chagas disease, induces in congenitally infected fetuses a strong, adult-like parasite-specific CD8
Introduction
Trypanosoma cruzi is the parasitic protozoan agent of Chagas' disease, a major cause of morbidity and mortality in Latin America, currently infecting 8-10 million persons [1] . One to 12% of T. cruzi-infected pregnant women transmit the parasite to their fetus [2, 3] . In a previous study, we showed that newborns congenitally infected with T. cruzi are able to overcome immunological immaturity and develop a parasite-specific CD8
? T cell response producing IFN-c. This pointed out that the fetal immune system is more competent than previously thought [4] .
Indeed, immune responses in early life are considered of limited effectiveness, owing to the relative immaturity of the human immune system. Such immaturity favors the logistics of vaccine administration later in childhood rather than during the neonatal period in spite of infectious diseases being a leading worldwide cause of morbidity and mortality in early life [5] . Neonatal immunity is initially polarized toward a Th2 immune environment which appears essential for the survival of the fetus [6, 7] . This, in conjunction with the hypermethylation of the IFN-c gene in neonatal CD4
? T cells, limits the development of Th1 cell responses essential for the control of intracellular pathogens [5, 8, 9] . However, besides T and B cell deficiencies, the limitations of neonatal immune response also relate to functional defects of antigen-presenting cells (APCs) [5, 10] .
Dendritic cells (DCs) are considered as the most potent APCs, stimulating memory, as well as naïve T cells, a property not shared by other APCs. After activation (associated with up-regulation of surface expression of MHC and co-stimulatory molecules as well as secretion of cytokines), they display the antigen in form of MHC-peptide complexes on their surface and present it to CD4
? and CD8
? T cells. Then, depending on the type of initial maturation signals, they polarize the resulting adaptive immune response [11] . Neonatal DCs display defective expression of co-stimulatory molecules [10, [12] [13] [14] [15] [16] and a deficient production of the type 1 polarizing cytokines interleukin (IL)-12 and IFN-b [17, 18] . They are less effective than adult DCs in stimulating T cell proliferation [19, 20] and induce a poor Th1 response [21, 22] .
Since fetuses congenitally infected with T. cruzi develop a strong parasite-specific CD8
? type 1 response, we evaluated the ability of T. cruzi to activate cord blood DCs, a question not addressed to date, and studied the capacity of such activated DCs to stimulate allogeneic reaction and cytokine production by human CD4
? and CD8 ? T cells, comparing such effect with that of their adult blood counterparts.
Materials and methods

Blood samples
Umbilical cord blood samples were collected from healthy newborns at the maternity ward of the Erasme Hospital (Brussels, Belgium) after obtaining informed consent from their mothers. Blood samples of healthy adults were obtained from volunteer donors. Blood collection was performed in agreement with the ULB ethical committee guidelines. All blood samples were collected in endotoxinfree heparinized tubes (Becton-Dickinson, Erembodegem, Belgium) and processed within 6 h of collection.
Trypanosoma cruzi parasites
Live T. cruzi trypomastigotes (TcVI genotype, Tulahuen strain [23] ) were obtained from the supernatant of cultured infected fibroblasts as described previously [24] . Parasites were verified to be Mycoplasma-free by PCR (VenorGeMMycoplasma detection Kit, Lucron Bioproducts, Sint Martens-Latem, Belgium).
Whole blood cell stimulation with T. cruzi parasites Two milliliters of whole blood samples was half-diluted in RPMI 1640 medium containing 2 mM L-glutamine, 25 mM HEPES, penicillin 100 U/mL, and streptomycin 100 lg/mL (Lonza, Verviers, Belgium). They were incubated with 10 6 or 10 7 live T. cruzi parasites/mL, lipopolysaccharide (LPS; from Escherichia coli 0111B4; 1 lg/mL; Sigma-Aldrich; Bornem-Belgium), or medium alone. In some experiments, IgG fraction purified from cord blood samples (containing or not T. cruzi-specific antibodies) was added at a final concentration of 0.5 mg/mL. After incubation for 16 h at 37°C in a humidified atmosphere containing 5% CO 2 , blood samples were submitted to flow cytometry analyses or used for obtaining mononuclear cells enriched in dendritic cells (eDCs).
Flow cytometry analysis of leukocytes
Blood samples were centrifuged at 450 g for 5 min at room temperature (RT) and half of the supernatant medium was discarded. The pellet was re-suspended in the remaining supernatant. Two hundred microliters of cell suspension was incubated with fluorochrome-labeled antibodies together with FcR blockage reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) for 20 min at room temperature in the dark. Erythrocytes were then lysed by adding 2 mL of FACS lysing solution (BD Biosciences) for 10 min at RT. After two washings with FACS wash buffer (BD Biosciences), cells were re-suspended in FACS fix solution (BD Biosciences). Data were acquired in four-color flow cytometry FACS Calibur cytometer and analyzed using the Cell Quest software (Becton-Dickinson version 6.0).
The following monoclonal antibodies (mAb) and their matched isotype controls were used: lineage cocktail 1-FITC (lin 1, containing Ab against CD3, CD14, CD16, CD19, CD20 and CD56), anti-CD34-FITC (clone 581), anti-CD11c-APC (clone B-ly6), anti-CD123-PE (clone 9F5), anti-HLA-DR-PerCP (clone L243), anti-CD40-PE (clone 5C3), anti-CD80-PE (clone L307.4), anti-CD83-PE (clone HB15e), anti-CD86-PE (clone 2331 FUN-1), anti-CD19-PE (clone 4G7), anti-CD14-FITC (clone M5E2), anti-CD56-APC (clone N901 NKH1), anti-CD3-PerCp (clone SK7), anti-CD8-APC (clone RPA-T8), and anti-CD45RO-PE (clone UCHL1) (all supplied by BD Biosciences). The following combinations of antibodies were used: (1) Lin-1-FITC (with CD34-FITC for cells of cord blood), HLA-DR-PerCP, CD123-PE, and CD11-APC for evaluating the proportions of myeloid and plasmocytoid dendritic cells (mDCs and pDCs respectively); (2) Lin-1-FITC, HLA-DR-PerCP, CD11c-APC and CD40, CD80, CD83, or CD86-PE for studying co-stimulatory molecules on DCs; (3) CD14-FITC, CD19-PE, CD3-PerCP, and CD56-APC for evaluating the proportions of cell subsets in mononuclear cells enriched in DCs and depleted of T cells; (4) CD3-PerCP, CD8-APC, and CD45RO-PE for analysis of T lymphocytes after mixed leukocyte reaction (MLR).
Analysis was made on DCs, defined as HLA-DR ? , lineage negative (lin -) cells expressing either CD11c (mDCs) or CD123 (pDCs). DCs were identified by the standard gating strategy previously described [25, 26] 
Preparation of DC-enriched mononuclear cells
In order to compensate the low frequency of dendritic cells in blood [27] , experiments were performed with mononuclear cells enriched in DCs and depleted in T cells (so called eDCs). Monocyte-derived DCs were not used since they may present different features than blood mDCs [28] . eDCs were obtained according to the procedure previously described with slight modifications [29] . Briefly, mononuclear cells were separated from whole blood [after overnight culture in presence of live T. cruzi (Tc-eDCs), LPS (LPS-eDCs) or medium alone (mock-eDCs)] by density gradient centrifugation over OptiPrep TM (density 1.068 g/mL, Axis-shield PoC AS, Oslo, Norway) at 520g for 15 min at 4°C. Cells at the interface were collected and washed twice in RPMI 1640 at 4°C. CD3
? T cells were then depleted using MACS (Magnetic Affinity Column Separation) and anti-CD3-coated magnetic microbeads as described by the manufacturer (Miltenyi Biotech). T lymphocyte-depleted mononuclear cells were washed and immediately used as stimulating cells in mixed leukocyte reaction (MLR). Cell viability, measured by Trypan Blue exclusion, always exceeded 95%. Flow cytometry analyses of eDCs cell fractions obtained from blood samples indicated they contained on average 1.5-3.5% mDCs, i.e., an enrichment of around tenfold of mDCs concentration as compared to circulating concentration [10] . T lymphocytes proportion remained \3%. Other cells were monocytes (31-64%), B lymphocytes (27-41%), and NK cells (4-17%).
Preparation of purified T cells
Mononuclear cells from cord and adult blood samples were isolated by centrifugation on Nycoprep density gradient (Nycomed Pharma AS, Oslo, Norway). T lymphocytes were then purified using MACS and microbeads coupled to anti-CD3 mAb (Miltenyi Biotec) as described by the manufacturer. Purity of CD3
? cells was [98% as assessed by FACS analysis. They were then labeled as previously described [30] by incubating 5 9 10 6 cells/mL in RPMI containing 0.25 lM carboxyfluorescein succinimidyl ester (CFSE) during 10 min at 37°C in a humidified atmosphere containing 5% CO 2 . Staining was stopped by adding an equal volume of fetal calf serum (Lonza) to cell suspension. Labeled cells were washed twice in RPMI and re-suspended in complete medium (CM) consisting of RPMI 1640 supplemented with 10% fetal calf serum, 1 mM Na-pyruvate, and 0.1 mM non-essential amino acids (both from Cambrex Bio Science, Wiesbaden, Germany). Cell viability measured by Trypan Blue exclusion was always superior to 95%.
Allogeneic mixed leukocyte reaction (MLR)
MLRs were performed in 96-well round-bottom microplates (Nunc, Roskilde, Denmark) in triplicates. CFSElabeled T lymphocytes (2 9 10 5 /well) were co-cultured without (control of spontaneous proliferation) or with eDCs at ratios of stimulating/responding cells of 1/10 and 1/100 in a final volume of 200 lL/well of CM. After 6 days of culture, cells were harvested, washed in PBS containing 1% of bovine serum albumine (Cambrex Bio Science), and stained with mAb anti-CD3-PerCP, anti-CD8-APC, and anti-CD45RO-PE as described above. Since the basal proliferation (with mock-eDCs) varied according to the degree of allogeneic MHC mismatches, the considered ratio between eDCs and T cells was that giving the best demarcation between the effect of mock-and T. cruzieDCs.
As the CFSE intensity of labeled lymphocytes reduced by half upon sequential cell divisions, we have determined for CD3
? , CD3 ? CD8 ? , or CD3 ? CD8 -cells: (1) the proportion of cells having proliferated, corresponding to the ratio CFSE low/neg cells/all T lymphocytes, (2) the frequency of T cell precursors having responded in MLR as described elsewhere [31] , and (3) the mean number of cell divisions (n) that proliferating cells had undergone at the time of read-out, calculated as follows: n = Log 2 (MFI of CFSE ? cells/MFI of CFSE low/neg cells)/Log 2 2) [32] . The percentage of proliferating T cells incubated in the absence of eDCs (low or negative) was deduced from results observed in presence of eDCs.
Cytokine assays
Cytokine levels were measured in MLR supernatants by ELISA. IFN-c was detected using antibody pairs and standard from Biosource (Invitrogen, Merelbeke, Belgium), whereas IL-13 and IL-17A levels were determined with commercially available kits from Bender MedSystems GmbH (Vienna, Austria), according to the manufacturer's instructions. Detection limits were 2 pg/mL for IFN-c and 0.5 pg/mL for IL-13 and IL-17. Spontaneous release of cytokines by T cells incubated in the absence of eDCs was either undetectable or very low. In the latter case, cytokine concentration was subtracted from levels obtained after stimulation with eDCs.
Purification of IgG
IgG fractions were prepared from plasma pools of cord blood samples of uninfected neonates born to T. cruziinfected-mothers (containing T. cruzi-specific antibodies; Ab?) or uninfected mothers (without T. cruzi-specific antibodies; Ab-), obtained in Bolivia from previous studies [4, 33] . IgG were purified by three sequential precipitations with ammonium sulfate 33% (w/w) final concentration, washed, dialyzed against PBS, and stored in small aliquots at -20°C at a concentration of 10 mg/mL until use (to avoid IgG aggregation after repeated thawing). IgG purity was assessed by SDS-PAGE. T. cruzi-specific antibodies remained undetectable in the Ab-fraction, whereas their titer determined by standard ELISA was C12,000 in the Ab? fraction. Distributions of IgG subclasses were verified to be similar in Ab? and Abfractions.
Expression of results and statistical analysis
Results are expressed either as means or Box and Whisker plots (showing medians, 5th-95th percentiles and extreme values). Statistical comparisons were performed with the Student t test or Mann-Whitney Wilcoxon U test (paired or not, depending on the analyzed data). Statistical analyses were conducted using GraphPad Prism software 5.02 (GraphPad Software Inc., San Diego, CA).
Results
Trypanosoma cruzi enables cord blood mononuclear cells to trigger proliferation of CD4
? and CD8 ? T cells
We first investigated whether eDCs from cord or adult blood cultured in the presence of T. cruzi (Tc-eDCs) were able to trigger proliferation of adult T cells in MLR. Figure 1a shows that Tc-eDCs from cord blood significantly enhanced T cell proliferation (as compared to mock-eDCs) to levels similar to those induced by LPS. Interestingly, this effect was more pronounced for CD8 ? than for CD4 ? T cells (fold increase in response to Tc-eDCs: 3.7 vs. 2.8, in response to LPS: 5.3 vs. 2.8), a feature not observed with adult Tc-eDCs (Fig 1b) . Figure 2 shows representative dot plots of T cells having proliferated in response to neonatal mock-and Tc-eDCs. Second, we analyzed the frequency of T cell precursors that had proliferated in response to eDCs and the mean number of cell division cycles they have undergone at the time of read-out (representative of their proliferation rate). Results in Table 1 show that cord blood eDCs activated by T. cruzi significantly increased the number of division cycles of CD4
? and CD8 ? T cells and also particularly the frequency of responding CD8
? precursors (as compared to mock-eDCs), all reaching levels similar to those obtained with LPS-eDCs. Effects of adult Tc-and LPS-eDCs were roughly similar than those of cord blood eDCs. Altogether, these results show that T. cruzi enables cord blood mononuclear cells to trigger proliferation of T lymphocytes, and particularly of CD8
? T cells, enhancing both the frequency of responding cells and their proliferation rate.
The above experiments were performed with T lymphocytes purified from adult blood samples known to contain both naïve (CD45RO -) and memory (CD45RO ? ) cells. We thus investigated the ability of cord blood TceDCs to induce proliferation of cord blood T lymphocytes (CD3 ? ), known to contain a majority of naïve T cells [34] . Figure 1c shows that such proliferation was significantly increased with Tc-eDCs and LPS-eDCs. Interestingly, the enhancing proliferative effect of cord blood Tc-eDCs on cord blood T cells was of similar amplitude than on adult T cells (3.2-and 3.0-fold increase, respectively; Fig. 1c vs. a). These data argue for the ability of T. cruzi-activated cord blood eDCs in promoting also responses of neonatal naïve T lymphocytes.
Proliferation of T cells induced by T. cruzi-activated cord blood mononuclear cells is associated with IFN-c release and IL-13 down-regulation As shown in Table 2 , IFN-c production in MLR supernatants of adult T cells was significantly increased by 3 times using cord blood Tc-eDCs (in comparison with mockeDCs), whereas IL-13 release was down-regulated by 1.4 times (leading to averages of 24 pg/mL for both cytokines), inducing a subsequent reduction in the IL-13/IFN-c mean level ratios from 2.8 to 1.2. Meanwhile, IL-17 production in response to cord blood Tc-eDCs remained unchanged as compared to mock-eDCs, by contrast with the effect of cord blood LPS-eDCs which mainly increased IL-17 levels. MLR with adult eDCs induced a different cytokine environment with an inverse basal IL-13/IFN-c ratio of 0.13 (mock-eDCs). Adult Tc-eDCs mainly boosted IFN-c and IL-17 responses, without significantly modifying IL-13 levels, whereas adult LPS-eDCs boosted the production of the three cytokines. These results show that, in response to T. cruzi, cord blood eDCs favor a type 1 cytokine environment without modifying IL-17 levels, whereas adult eDCs generated a still better type 1 response alongside with enhancing IL-17 release.
Trypanosoma cruzi induces surface expression of co-stimulatory molecules on neonatal myeloid DCs Among APCs, dentritic cells have been shown to mainly account for the allostimulatory activity, in relation to their ability to express high levels of MHC-peptide complexes and co-stimulatory molecules [35, 36] . We therefore studied the expression of HLA-DR and co-stimulatory molecules (CD40, CD80, CD83 and CD86) on both main circulating DC subsets, the myeloid and plasmocytoid DCs (mDCs and pDCs, respectively), from cord and adult whole blood samples cultured overnight in the presence of T. cruzi. In agreement with previous reports, mDCs and pDCs levels were similar in cord blood while adult blood contained on average 2-3 times more mDCs than pDCs [10, 16] . These proportions were not modified after overnight culture with T. cruzi or LPS (data not shown).
Analyses of data obtained from cord blood and adult plasmocytoid DCs indicated that T. cruzi hardly triggered the surface expression of HLA-DR, CD40, CD80, CD83, and CD86 (data not shown). By contrast, as shown in Fig. 3 , cord blood and adult myeloid DCs incubated in the presence of T. cruzi displayed significant increases in the percentages of cells expressing co-stimulatory molecules and of MFI for these markers, with the exception of CD86 on cord blood mDCs which displayed basal high expression after culture as described elsewhere [37, 38] . Meanwhile, HLA-DR expression was not modified on cord blood mDCs and slightly increased on adult mDCs. Interestingly, expression of co-stimulatory molecules on cord blood incubated with T. cruzi reached levels close to (CD40 and CD80) or higher (CD83, P \ 0.05) than those observed on adult mDCs. LPS, used as positive control, had a stronger enhancing effect on CD40, CD80, and CD86 expression on cord blood and adult mDCs. Figure 4 shows the results of a representative experiment indicating a marked up-regulation of CD40 expression depending on parasite levels by cord blood mDCs, peaking at a parasite/leukocyte ratio of 1 (i.e., 10 7 T. cruzi/mL). This indicates that T. cruzi is able to induce the expression of co-stimulatory molecules on cord blood mDCs.
Trypanosoma cruzi-specific IgG increases the expression of co-stimulatory molecules induced by parasites on cord blood myeloid DC Newborns from T. cruzi-infected mothers harbor maternally transmitted parasite-specific IgG. As mDCs express FccR [39] , we investigated whether T. cruzi-specific IgG (Ab?) could modulate the expression of CD40, CD80, and ? cells were co-cultured with mock-or Tc-eDCs from cord blood samples at a ratio 10:1. After 6 days, cells were harvested and stained with anti-CD3-PerCp and anti-CD8-APC mAb. The proportions of proliferating CD4
? (CD8 -) and CD8 ? T cells (MFI CFSE \100) are indicated in the left quadrant (data from one representative experiment from 6 giving similar results) HLA-DR induced by the parasite on mDCs. Incubation of cord blood samples with Ab? in the absence of parasites did not modify the basal expression of these molecules on mDCs (data not shown). As shown in Fig. 5a , mDCs from cord blood samples cultured overnight in the presence of T. cruzi and Ab? significantly increased their expression of CD40 and CD80 (percentage of positive cells and/or MFI), while a minimal effect was observed for HLA-DR expression. A similar effect was observed on CD40 and CD80 expression using adult mDCs (Fig. 5b) . The same experiment performed with the Ab-control had no significant effect on the expression of these markers on both adult and cord blood mDCs (Fig. 5a, b) . This suggests that maternal IgG antibodies could improve T. cruzi-induced activation of cord blood mDCs.
Discussion
Altogether, our results show that (1) T. cruzi enables cord blood mononuclear cells enriched in DCs (eDCs) to stimulate proliferation of neonatal as well as adult T lymphocytes; (2) the response of (adult) CD8 positive T cells to cord blood eDCs was more pronounced than that of CD8 negative T cells; (3) proliferation of adult T cells in response to cord blood Tc-eDCs is associated with IFN-c release and down-regulation of IL-13 production; (4) T. cruzi induces the surface expression of co-stimulatory molecules on myeloid DCs (mDCs) from cord and adult blood; (5) parasite-specific antibodies enhance expression of such co-stimulatory molecules on cord blood mDCs activated by T. cruzi.
Though our study is mainly focused on neonatal immune response, it is worth noting that, to our knowledge, this is the first demonstration that T. cruzi induces maturation of human mDCs found in blood, by up-regulating their surface expression of MHC class II and co-stimulatory molecules. This agrees with two reports showing activation by T. cruzi recombinant molecules of human dendritic cells differentiated in vitro from blood monocytes (MoDCs) [40, 41] . Other studies showed that interaction of T. cruzi parasites with MoDCs inhibited their response to LPS [42, 43] . Nevertheless, in our experimental conditions of co-culture of cord blood cells and live parasites, T. cruzi endowed human eDCs (containing activated mDCs) to induce significant proliferation of both CD8
-and CD8 ? T cells as well as to produce cytokines. We may speculate that parasite-activated human mDCs were primarily responsible for T cell responses since monocytes and B cells, also present in eDCs, have been described to hardly contribute to allogeneic responses [35, 36] , and that among blood DCs, the myeloid subset is more potent in activating T cells than pDCs [10, 44] .
Cord blood eDCs, whatever activated by T. cruzi or LPS, induced a predominant response of CD8
? over CD4
? T cells. This was not observed in response to adult Tc-eDCs. The mechanisms endowing neonatal eDCs to preferentially expand CD8 ? T cells in response to pathogens are unknown. This is reminiscent of previous observations from us and others showing the development of a mature and functional CD8
? T cell response in neonates congenitally infected with T. cruzi [4] , hCMV [45] , or HIV [46] . Such preferential expansion of CD8 T cells might be related to the particular enhancement of CD83 expression on activated cord blood DCs, a molecule reported to be important in activation of CD8
? T cells [47] [48] [49] and participating, with other co-stimulatory molecules, to increase the frequency of T cell precursors [50, 51] as observed in a Mononuclear cells enriched in DCs (eDCs) prepared after overnight incubation with 10 6 live T. cruzi trypomastigotes/ml, LPS (1 lg/mL), or medium alone (mock) were used as stimulatory cells against purified adult T lymphocytes as responder cells; cytokines were measured by ELISA in supernatants after 6 days of culture b Geometric means (percentiles 25-75%) of 5-6 individual samples per group our experiments. A non-exclusive possibility relates to a bystander activation by cytokines, produced by DCs or other cell types present in eDCs, to which CD8
? T cells are more sensitive than CD4
? T cells [52, 53] , particularly in infectious contexts [54] [55] [56] .
Another interesting result is that T. cruzi-activated cord blood eDCs favored the production of IFN-c over IL-13, whereas in the absence of parasites, cord blood eDCs displayed a type 2 response releasing higher levels of IL-13, as previously described [21, 22] . We can reasonably hypothesize that CD8
? rather than CD4 ? are the main source of IFN-c detected in the supernatant of T cells co-cultured with neonatal Tc-eDCs. Indeed, CD8
? T cells are predominantly expanded, neonatal DCs are poor producers of IL-12p70 [17] , a key cytokine for Th1 differentiation of CD4
? T cells, while CD8 ? T cells can produce IFN-c through an IL-12-independent pathway [57] . This is in line with our previous work showing a preferential IFN-c production by the CD8
? T cells from neonates congenitally infected with T. cruzi [4] . A concomitant production of IFN-c by NK cells, besides T cells, cannot be excluded since such cells are also present in eDCs preparations [58, 59] .
Activation of T cells depends on strength and duration of TCR/CD3/CD4 or TCR/CD3/CD8 engagement by peptide-MHC complexes (pMHC) as well as on co-stimulatory signals [60] [61] [62] . In our study, the TCRs recognizing alloantigens are expected to be similar on T cells co-cultured with mock-or T. cruzi-activated eDCs. Hence, the enhanced expression of co-stimulatory molecules induced by T. cruzi on DCs is expected to mainly account for the observed increased T cell proliferation. Indeed, T. cruzi induced a nearly similar (CD40, CD80) to higher (CD83) expression of co-stimulatory molecules on cord and adult blood mDCs, suggesting that the parasite tends to trigger an adult-like maturation of neonatal DCs, even if it did not reach the level induced by a high dose of LPS. Particularly, CD28 engagement by CD80/CD86, known to favor fast production of IL-2 and T cell proliferation [50, 51] , likely accounts for the observed effect of T. cruzi. Additionally, up-regulated CD40 expression on mDCs by the parasite contributed to boost DC maturation [63] , as indicated by increased CD83 expression on T. cruzi-stimulated DCs, a cell surface marker considered as the most characteristic of immunocompetent DCs [48, 64] . Moreover, CD83 expression in response to T. cruzi was superior on cord blood as compared with adult mDCs, whereas this particularity was not observed in response to LPS and has not been reported previously in response to other microorganisms. On the contrary, pertussis toxin and M. bovis Bacilli Calmette-Guerin (BCG) do not modify significantly CD83 expression on neonatal mDCs while they induced it on adult cells [26, 65] . Such results suggest that CD83 surface expression might be differently regulated in neonatal and adult DCs and that T. cruzi likely allows superior translocation of preformed CD83 on cord blood mDCs than do LPS and/or limits its shedding [66, 67] .
Interestingly, the proliferative response of T cells to eDCs activated by T. cruzi was comparable to that induced by eDCs activated by LPS, known to be a very effective DC activator. This underlines the significant potency of T. cruzi to license eDCs to activate T cell responses. Comparable effects of T. cruzi and LPS are achieved despite the parasite induces lower levels of co-stimulatory molecules. This suggests that co-stimulatory signals other than those we have studied [68] may be differently modulated by T. cruzi and LPS and/or that a bystander activation of T cells [52] in response to T. cruzi occurs. The activating effect of T. cruzi on cord blood mDCs might rely on the simultaneous engagement of multiple surface pattern recognition receptors which are susceptible to recognize the parasite [69, 70] . However, Toll-like receptor (TLR)4 and TLR9 are probably not involved in the activation of such cells. Indeed, though TLR9 recognizes T. cruzi DNA sequences [71] , it is only expressed on pDCs in humans [72] , whereas cord blood eDCs activation was mainly observed in mDCs. Moreover, the engagement of TLR4 by some surface molecules of T. cruzi [73] and/or its PAMP-independent activation by parasite trans-sialidases [74] are also unlikely. Indeed, IL-17 production by cord blood mDCs was not stimulated by the parasite, at odds with the previously described ability of TLR4 engagement by LPS to induce this cytokine through the production of IL-23 [75] . Cross-talk with other cells present in our assays, like NK cells, might also indirectly contribute to improve DC activation [76] [77] [78] . Arguing for this, T. cruzi is able to rapidly activate NK cells [59] .
The increased expression of co-stimulatory molecules on cord blood mDCs in response to T. cruzi in the presence of parasite-specific IgG as compared to parasites alone is of particular interest in the maternal-fetal context. Indeed, maternally transmitted antibodies are present at high levels in utero and after birth in both congenitally infected and uninfected fetuses/newborns of T. cruzi-infected mothers [3] . This indicates that, besides TLR or other receptors recognizing T. cruzi molecules, FccRs strengthen DC activation. Indeed, FccRs are known to be expressed by DCs and to induce their maturation via the NF-jB signaling pathway [39, 79, 80] . Both soluble circulating T. cruzi molecules (under immune complexes form) and/or opsonised parasites might contribute to this effect by aggregating FccR on DCs surface as well as by enhancing parasite internalization. Our results suggest the new idea that maternally transmitted antibodies, besides their capacity to neutralize pathogens, might contribute to overcome some defects of fetal/neonatal DCs and to protect the fetus/newborn against pathogens already encountered by his mother.
In conclusion, the present work indicates that T. cruzi has a significant stimulating effect on human cord blood mDCs, amplified in the presence of parasite-specific Abs, contributing to overcome some defects of fetal/neonatal DCs. It also highlights the need for complementary studies on the cord blood DC receptors recognizing the parasite, the role of molecules released from killed or live parasites and/or of T. cruzi-intracellular infection on their activation, as well as to better characterize the ensuing T cell response.
